Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2002

View Archived Issues

rSP-C surfactant treatment tends to reduce mortality in patients with ARDS

Merck and Tularik present novel HIV integrase inhibitors

Novel MMP inhibitors identified by Pfizer research group

Gastric antisecretory agents patented by Byk Gulden

Novel retinoids and their use in pulmonary emphysema, cancer and skin disorders

NMDA channel blockers identified by U.S. university researchers

Prednisone prolongs survival in multiple myeloma patients

Novel protein kinase inhibitors discovered at Pfizer

Genta initiates gallium nitrate program for NHL

Antibacterial and antiinflammatory agents claimed by SUNY

Antisense compound identified with potential in cardiovascular disease

HGS and CAT to develop TRAIL-R2 MAb

ISS-1018 enters phase I in asthma

Amantadine as an effective and safe alternative to interferon in HCV infection

Selective CCKB/gastrin receptor antagonist evaluated in rat model of GERD

Rabeprazole effective for heartburn and symptoms of NERD

Novel antidiabetic lowers only elevated blood glucose levels and stimulates insulin release

Antigen-induced bronchospasm ameliorated by treatment with SOD mimetic

New data on treprostinil discussed at ATS 2002

Blockade of IL-5 with MAb selectively reduces eosinophils in bone marrow and peripheral blood

Low-dose formulation of Retin-A Micro approved by FDA

NicOx and Axcan sign codevelopment and license agreement for NCX-1000 in chronic liver diseases

Panacea receives SBIR grant for anti-HAAH cancer drugs

FDA advisory committee supports efficacy of Prevnar in otitis media

Pharmagene and Argenta Discovery collaborate on migraine and IBS programs

Restoragen restructures and refocuses

Phase I trial begins for first candidate to emerge from Vernalis/Roche obesity collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...